NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

On Tuesday, ARS Pharmaceuticals Inc. (NASDAQ:SPRY) announced a leadership transition. Co-founder and

ARS Pharma (SPRY) co-founder Richard Lowenthal steps down as CEO. President Donn Casale succeeds him

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-ris

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of  Leadershi

ARS Pharmaceuticals stock lost more than 23% of its value in a single after-hours session after Neff

NEW YORK--(BUSINESS WIRE)--Shareholders who held ARS Pharmaceuticals (NASDAQ: SPRY) stock watched th

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

ARS Pharmaceuticals Investigation Initiated: Levi and Korsinsky Investigates the Officers and Direct

ARS Pharmaceuticals CEO projected CVS Caremark formulary inclusion was expected for the July 1, 2026

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it i

LOS ANGELES--(BUSINESS WIRE)---- $SPRY--SPRY Investors Have Opportunity to Join ARS Pharmaceuticals,

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) on Wednesday reaffirmed its expectation to achieve cash-flow

ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

U.S. stocks traded mostly higher, with the Nasdaq Composite down 0.1%. Industrials jumped 2.5%, whil

Leerink Partners analyst Roanna Ruiz maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperfor

ARS Pharmaceuticals stock collapsed Thursday after CVS Caremark declined to add its epinephrine spra

U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release a

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

Shares of Micron Technology Inc (NASDAQ: MU) surged in pre-market trading after reporting strong Q3

SPRY stock drops after ARS says no new neffy coverage decisions in July formulary cycle.

Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-

No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spra

Access and payer coverage: Despite certain payer discussions ongoing until mid-June, based on recent

No new commercial formulary additions or coverage decisions issued for  neffy (epinephrine nasal spr

ARS Pharmaceuticals is now focused on scaling Neffy. This is their needle-free epinephrine spray for

ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals NASDAQ: SPRY reported first-quarter 2026 revenue of $22.7 million as executives

The CNN Business Fear & Greed Index, a measure of market sentiment, improved slightly on Thursda

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

Aquestive received an FDA rejection for its allergy film due to safety and use issues. The company p

ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's a

Aquestive Therapeutics shares fall after the FDA flags deficiencies in its Anaphylm allergy drug app

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, l